BIB:NASDAQ
ProShares Ultra Nasdaq Biotechnology
US$ 106.88
arrow_downward
-4.62%(-5.18) Siku 1
6 Okt, 16:00:00 GMT -4 · USD
search
Alama zote
| Alama | Bei | Tofauti | Tofauti ya asilimia |
|---|
insights_autoInatayarisha maarifa maarufu ya BIB...
Fungua
US$ 112.80
Juu
US$ 112.80
Chini
US$ 105.48
Wastani wa kiasi cha mauzo
elfu 8.63
Kiasi cha mauzo ya hisa
2.00
Juu kwa wiki 52
US$ 126.40
Chini kwa wiki 52
US$ 62.72
Beta
1.20
Fungua
US$ 112.80
Juu
US$ 112.80
Chini
US$ 105.48
Wastani wa kiasi cha mauzo
elfu 8.63
Kiasi cha mauzo ya hisa
2.00
Juu kwa wiki 52
US$ 126.40
Chini kwa wiki 52
US$ 62.72
Beta
1.20
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
Simply Wall Street
·
dakika 2 zilizopita
Neurocrine Biosciences (NBIX) After New VYKAT XR Data Why The Undervalued Narrative Persists
Yahoo Finance
·
saa 1 iliyopita
S&P 500, Nasdaq hit records — but 'the breadth of the rally has narrowed': Chart of the Day
The Motley Fool
·
dakika 8 zilizopita
Is the S&P 500 Historically Expensive or Cheap? The Answer Depends on How You Look at It.
AOL.com
·
saa 1 iliyopita
2 Vanguard ETFs Outpacing the S&P 500 and Nasdaq-100 This Year but Facing Near-Term Tests